Ono Pharmaceutical Co. Ltd
Investigate the efficacy and safety of ONO-4538 in patients with Richter's transformation
Richter's Transformation
ONO-4538
PHASE2
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 14 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | A Multicenter, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of ONO-4538 in Patients With Richter's Transformation |
Actual Study Start Date : | 2025-09 |
Estimated Primary Completion Date : | 2029-07-31 |
Estimated Study Completion Date : | 2030-07-31 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
NOT YET RECRUITING
Hokkaido University Hospital
Sapporo, Hokkaido, Japan, 060-8648
NOT YET RECRUITING
National Cancer Center Hospital
C goods Ku, Tokyo, Japan,
RECRUITING
Kyusyu University Hospital
Fukuoka, Japan, 812-8582